-
Credit Agencies to Remove Some Medical Debt From Reports
Changes to what medical debt is included in credit reports could give patients more time to resolve outstanding bills.
by Karon Warren
-
The Mental Toll of a Cancer Diagnosis
New studies shine a light on the effects of a cancer diagnosis on mental health and suicide risk.
by Pamela Rafalow Grossman
-
Access to Health Insurance Key to Disparities in Cancer Outcomes
As outcomes improved for cancer patients in states that expanded Medicaid, disparities in survival disappeared.
by Jon Kelvey
-
T Cells Key to COVID-19 Vaccination Efforts
Experts discuss shortcomings of current COVID-19 vaccines in people with cancer while highlighting possibilities of T-cell activation.
by Thomas Celona
-
Exploring Amino Acids’ Impact on Tumor Growth
Researchers are investigating how to match specific dietary changes with therapy to impede cancer progression.
by Thomas Celona
-
Understanding Stress and Cancer
A symposium at the AACR Annual Meeting explores how social factors contribute to elevated risk of cancer in some populations.
by Eric Fitzsimmons
-
The Impact of the RACE for Children Act
Legislation to speed cancer drug development for children and adolescents requires drug companies to test drugs in children, but trials in people under 18 may take years to generate results.
by Marci A. Landsmann
-
Making Collaboration More Common for Rare Cancers
An AACR Annual Meeting 2022 session highlights the impact of research advocacy partnerships for a variety of cancers.
by Marci A. Landsmann
-
Second DCIS Diagnoses May Not Be Related to Initial Lesion
DNA sequencing found that in many cases when DCIS recurred, the lesion was unrelated to the first diagnosis, raising questions about how to best treat recurrence.
by Eric Fitzsimmons
-
How COVID-19 Changed Cancer Care
A new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.
by Eric Fitzsimmons
Cancer Talk
Immunotherapy Improves Survival in Bladder Cancer
New research indicates that adding immunotherapy to muscle-invasive bladder cancer treatment can improve event-free and overall survival.
by Laura Gesualdi-Gilmore
Cancer Patients Who Quit Smoking, Even Years After Diagnosis, Live LongerFindings from a recent study support smoking cessation after diagnosis, with the most pronounced effect in those who received treatment within six months of diagnosis.
by Kyle Bagenstose
Delaying Treatment ResistanceAdding a CDK 4/6 inhibitor extends progression-free survival for people with metastatic HR-positive, HER2-positive breast cancer.
by Thomas Celona
2024: The Year in Cancer NewsThe Cancer Today editors share the most impactful reporting on cancer research from 2024.
by Cancer Today staff